These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32867586)

  • 1. Efficacy and safety of mexiletine in amyotrophic lateral sclerosis: a systematic review of randomized controlled trials.
    Adiao KJB; Espiritu AI; Bagnas MAC
    Neurodegener Dis Manag; 2020 Dec; 10(6):397-407. PubMed ID: 32867586
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression.
    Weiss MD; Macklin EA; Simmons Z; Knox AS; Greenblatt DJ; Atassi N; Graves M; Parziale N; Salameh JS; Quinn C; Brown RH; Distad JB; Trivedi J; Shefner JM; Barohn RJ; Pestronk A; Swenson A; Cudkowicz ME;
    Neurology; 2016 Apr; 86(16):1474-81. PubMed ID: 26911633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single blind randomized controlled clinical trial of mexiletine in amyotrophic lateral sclerosis: Efficacy and safety of sodium channel blocker phase II trial.
    Shibuya K; Misawa S; Kimura H; Noto Y; Sato Y; Sekiguchi Y; Iwai Y; Mitsuma S; Beppu M; Watanabe K; Fujimaki Y; Tsuji Y; Shimizu T; Mizuno T; Nakagawa M; Sawaguchi K; Hanaoka H; Kuwabara S
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(5-6):353-8. PubMed ID: 25960085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trial.
    Weiss MD; Macklin EA; McIlduff CE; Vucic S; Wainger BJ; Kiernan MC; Goutman SA; Goyal NA; Rutkove SB; Ladha SS; Chen IA; Harms MB; Brannagan TH; Lacomis D; Zivkovic S; Ma M; Wang LH; Simmons Z; Rivner MH; Shefner JM; Cudkowicz ME; Atassi N;
    Muscle Nerve; 2021 Mar; 63(3):371-383. PubMed ID: 33340120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized double-blind personalized N-of-1 clinical trial to test the safety and potential efficacy of TJ-68 for treating muscle cramps in amyotrophic lateral sclerosis (ALS): study protocol for a TJ-68 trial.
    Mitsumoto H; Cheung K; Oskarsson B; Andrews HF; Jang GE; Andrews JA; Shah JS; Fernandes JA; McElhiney M; Santella RM
    Trials; 2023 Jul; 24(1):449. PubMed ID: 37430314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Studies in Management of Muscle Cramps.
    Katzberg HD
    Neurol Clin; 2020 Aug; 38(3):679-696. PubMed ID: 32703476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease.
    Baldinger R; Katzberg HD; Weber M
    Cochrane Database Syst Rev; 2012 Apr; (4):CD004157. PubMed ID: 22513921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Motor nerve hyperexcitability in ALS: its pathophysiology and treatment].
    Shibuya K; Misawa S; Kuwabara S
    Rinsho Shinkeigaku; 2014; 54(12):1086-8. PubMed ID: 25672715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial.
    Weber M; Goldman B; Truniger S
    J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1135-40. PubMed ID: 20498181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cramps and vinpocetine in ALS.
    de Carvalho M
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):155-156. PubMed ID: 28931329
    [No Abstract]   [Full Text] [Related]  

  • 11. Voltage-Gated Sodium Channel Blockers: Synthesis of Mexiletine Analogues and Homologues.
    Catalano A; Franchini C; Carocci A
    Curr Med Chem; 2021; 28(8):1535-1548. PubMed ID: 32364065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open-label pilot study of ranolazine for cramps in amyotrophic lateral sclerosis.
    Chandrashekhar S; Hamasaki AC; Clay R; McCalley A; Herbelin L; Pasnoor M; Jawdat O; Dimachkie MM; Barohn RJ; Statland J
    Muscle Nerve; 2022 Jul; 66(1):71-75. PubMed ID: 35466411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Mexiletine on Muscle Stiffness in Patients With Nondystrophic Myotonia Evaluated Using Aggregated N-of-1 Trials.
    Stunnenberg BC; Raaphorst J; Groenewoud HM; Statland JM; Griggs RC; Woertman W; Stegeman DF; Timmermans J; Trivedi J; Matthews E; Saris CGJ; Schouwenberg BJ; Drost G; van Engelen BGM; van der Wilt GJ
    JAMA; 2018 Dec; 320(22):2344-2353. PubMed ID: 30535218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mexiletine for muscle cramps in amyotrophic lateral sclerosis: A randomized, double-blind crossover trial.
    Oskarsson B; Moore D; Mozaffar T; Ravits J; Wiedau-Pazos M; Parziale N; Joyce NC; Mandeville R; Goyal N; Cudkowicz ME; Weiss M; Miller RG; McDonald CM
    Muscle Nerve; 2018 Mar; ():. PubMed ID: 29510461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Safety and Efficacy of Mexiletine for Patients With Skeletal Muscle Channelopathies.
    Suetterlin KJ; Bugiardini E; Kaski JP; Morrow JM; Matthews E; Hanna MG; Fialho D
    JAMA Neurol; 2015 Dec; 72(12):1531-3. PubMed ID: 26658970
    [No Abstract]   [Full Text] [Related]  

  • 16. Muscle cramp in Machado-Joseph disease: altered motor axonal excitability properties and mexiletine treatment.
    Kanai K; Kuwabara S; Arai K; Sung JY; Ogawara K; Hattori T
    Brain; 2003 Apr; 126(Pt 4):965-73. PubMed ID: 12615652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flecainide in Amyotrophic Lateral Sclerosis as a Neuroprotective Strategy (FANS): A Randomized Placebo-Controlled Trial.
    Park SB; Vucic S; Cheah BC; Lin CS; Kirby A; Mann KP; Zoing MC; Winhammar J; Kiernan MC
    EBioMedicine; 2015 Dec; 2(12):1916-22. PubMed ID: 26844270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and safety of mexiletine versus placebo in patients with myotonia: a systematic review and meta-analysis.
    Elettreby AM; Elnaga AAA; Alsaied MA; Ewis DK; Sharkawy AM; Fareed R; Alderbi GM
    Neurol Sci; 2024 Aug; 45(8):3989-4001. PubMed ID: 38403671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mexiletine in Myotonic Dystrophy Type 1: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Heatwole C; Luebbe E; Rosero S; Eichinger K; Martens W; Hilbert J; Dekdebrun J; Dilek N; Zizzi C; Johnson N; Puwanant A; Tawil R; Schifitto G; Beck CA; Richeson JF; Zareba W; Thornton C; McDermott MP; Moxley R
    Neurology; 2021 Jan; 96(2):e228-e240. PubMed ID: 33046619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.